nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—MPO—Carboplatin—brain cancer	0.39	1	CbGbCtD
Octreotide—SSTR5—hindbrain—brain cancer	0.0154	0.0683	CbGeAlD
Octreotide—SSTR3—hindbrain—brain cancer	0.0147	0.0655	CbGeAlD
Octreotide—SSTR1—hindbrain—brain cancer	0.0117	0.0518	CbGeAlD
Octreotide—SSTR2—hindbrain—brain cancer	0.00991	0.044	CbGeAlD
Octreotide—SSTR4—telencephalon—brain cancer	0.0092	0.0409	CbGeAlD
Octreotide—SSTR5—brainstem—brain cancer	0.00882	0.0392	CbGeAlD
Octreotide—SSTR3—brainstem—brain cancer	0.00845	0.0376	CbGeAlD
Octreotide—SSTR1—brainstem—brain cancer	0.00668	0.0297	CbGeAlD
Octreotide—SSTR5—pituitary gland—brain cancer	0.00637	0.0283	CbGeAlD
Octreotide—SSTR3—pituitary gland—brain cancer	0.00611	0.0271	CbGeAlD
Octreotide—SSTR1—telencephalon—brain cancer	0.00593	0.0263	CbGeAlD
Octreotide—SSTR4—endocrine gland—brain cancer	0.0058	0.0258	CbGeAlD
Octreotide—SSTR4—head—brain cancer	0.00573	0.0255	CbGeAlD
Octreotide—SSTR2—brainstem—brain cancer	0.00568	0.0252	CbGeAlD
Octreotide—SSTR4—central nervous system—brain cancer	0.00523	0.0232	CbGeAlD
Octreotide—SSTR2—telencephalon—brain cancer	0.00504	0.0224	CbGeAlD
Octreotide—SSTR5—endocrine gland—brain cancer	0.00494	0.0219	CbGeAlD
Octreotide—SSTR1—pituitary gland—brain cancer	0.00483	0.0215	CbGeAlD
Octreotide—SSTR3—endocrine gland—brain cancer	0.00473	0.021	CbGeAlD
Octreotide—SSTR3—head—brain cancer	0.00467	0.0208	CbGeAlD
Octreotide—SSTR5—cerebellum—brain cancer	0.00435	0.0193	CbGeAlD
Octreotide—MPO—endothelium—brain cancer	0.00427	0.019	CbGeAlD
Octreotide—SSTR3—central nervous system—brain cancer	0.00426	0.0189	CbGeAlD
Octreotide—SSTR1—midbrain—brain cancer	0.00426	0.0189	CbGeAlD
Octreotide—SSTR3—cerebellum—brain cancer	0.00417	0.0185	CbGeAlD
Octreotide—SSTR4—brain—brain cancer	0.00415	0.0184	CbGeAlD
Octreotide—SSTR2—pituitary gland—brain cancer	0.00411	0.0182	CbGeAlD
Octreotide—MPO—blood vessel—brain cancer	0.00394	0.0175	CbGeAlD
Octreotide—SSTR1—endocrine gland—brain cancer	0.00374	0.0166	CbGeAlD
Octreotide—SSTR1—head—brain cancer	0.00369	0.0164	CbGeAlD
Octreotide—SSTR3—brain—brain cancer	0.00339	0.015	CbGeAlD
Octreotide—SSTR1—central nervous system—brain cancer	0.00337	0.015	CbGeAlD
Octreotide—SSTR1—cerebellum—brain cancer	0.00329	0.0146	CbGeAlD
Octreotide—SSTR2—endocrine gland—brain cancer	0.00318	0.0141	CbGeAlD
Octreotide—SSTR2—head—brain cancer	0.00314	0.0139	CbGeAlD
Octreotide—SSTR2—central nervous system—brain cancer	0.00287	0.0127	CbGeAlD
Octreotide—SSTR2—cerebellum—brain cancer	0.0028	0.0124	CbGeAlD
Octreotide—SSTR1—brain—brain cancer	0.00268	0.0119	CbGeAlD
Octreotide—SSTR2—brain—brain cancer	0.00228	0.0101	CbGeAlD
Octreotide—MPO—pituitary gland—brain cancer	0.00155	0.00691	CbGeAlD
Octreotide—MPO—spinal cord—brain cancer	0.00134	0.00594	CbGeAlD
Octreotide—MPO—endocrine gland—brain cancer	0.0012	0.00535	CbGeAlD
Octreotide—MPO—head—brain cancer	0.00119	0.00528	CbGeAlD
Octreotide—MPO—central nervous system—brain cancer	0.00109	0.00482	CbGeAlD
Octreotide—MPO—brain—brain cancer	0.000862	0.00383	CbGeAlD
Octreotide—Dry mouth—Procarbazine—brain cancer	0.000638	0.00251	CcSEcCtD
Octreotide—Anaphylactoid reaction—Etoposide—brain cancer	0.000636	0.0025	CcSEcCtD
Octreotide—Vomiting—Lomustine—brain cancer	0.000626	0.00247	CcSEcCtD
Octreotide—Oedema—Procarbazine—brain cancer	0.000625	0.00246	CcSEcCtD
Octreotide—Dysuria—Temozolomide—brain cancer	0.000622	0.00245	CcSEcCtD
Octreotide—Infection—Procarbazine—brain cancer	0.000621	0.00245	CcSEcCtD
Octreotide—Hyperglycaemia—Carmustine—brain cancer	0.000621	0.00244	CcSEcCtD
Octreotide—Upper respiratory tract infection—Temozolomide—brain cancer	0.000618	0.00243	CcSEcCtD
Octreotide—Pneumonia—Carmustine—brain cancer	0.000617	0.00243	CcSEcCtD
Octreotide—Shock—Procarbazine—brain cancer	0.000615	0.00242	CcSEcCtD
Octreotide—Pollakiuria—Temozolomide—brain cancer	0.000614	0.00242	CcSEcCtD
Octreotide—Thrombocytopenia—Procarbazine—brain cancer	0.000612	0.00241	CcSEcCtD
Octreotide—Depression—Carmustine—brain cancer	0.000612	0.00241	CcSEcCtD
Octreotide—Tachycardia—Procarbazine—brain cancer	0.00061	0.0024	CcSEcCtD
Octreotide—Weight increased—Temozolomide—brain cancer	0.000605	0.00238	CcSEcCtD
Octreotide—Hyperhidrosis—Procarbazine—brain cancer	0.000604	0.00238	CcSEcCtD
Octreotide—Alopecia—Hydroxyurea—brain cancer	0.000602	0.00237	CcSEcCtD
Octreotide—Weight decreased—Temozolomide—brain cancer	0.000601	0.00237	CcSEcCtD
Octreotide—Neuropathy peripheral—Carmustine—brain cancer	0.000601	0.00237	CcSEcCtD
Octreotide—Hyperglycaemia—Temozolomide—brain cancer	0.0006	0.00236	CcSEcCtD
Octreotide—SSTR5—GPCR ligand binding—SMO—brain cancer	0.000597	0.00456	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—PTCH1—brain cancer	0.000597	0.00456	CbGpPWpGaD
Octreotide—Urinary tract infection—Carmustine—brain cancer	0.000596	0.00235	CcSEcCtD
Octreotide—Pneumonia—Temozolomide—brain cancer	0.000596	0.00235	CcSEcCtD
Octreotide—Anorexia—Procarbazine—brain cancer	0.000596	0.00235	CcSEcCtD
Octreotide—Erythema—Hydroxyurea—brain cancer	0.000593	0.00233	CcSEcCtD
Octreotide—Depression—Temozolomide—brain cancer	0.000591	0.00233	CcSEcCtD
Octreotide—Nausea—Lomustine—brain cancer	0.000585	0.0023	CcSEcCtD
Octreotide—Neuropathy peripheral—Temozolomide—brain cancer	0.000581	0.00229	CcSEcCtD
Octreotide—SSTR2—GPCR ligand binding—SHH—brain cancer	0.000581	0.00444	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PTCH2—brain cancer	0.000579	0.00442	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—ABR—brain cancer	0.000579	0.00442	CbGpPWpGaD
Octreotide—Urinary tract infection—Temozolomide—brain cancer	0.000576	0.00227	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—OR4C12—brain cancer	0.000575	0.00439	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—OR14C36—brain cancer	0.000575	0.00439	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PTCH2—brain cancer	0.000575	0.00439	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—DTX2—brain cancer	0.000575	0.00439	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—IL2—brain cancer	0.000573	0.00438	CbGpPWpGaD
Octreotide—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00057	0.00224	CcSEcCtD
Octreotide—Insomnia—Procarbazine—brain cancer	0.000566	0.00223	CcSEcCtD
Octreotide—Paraesthesia—Procarbazine—brain cancer	0.000561	0.00221	CcSEcCtD
Octreotide—Hepatobiliary disease—Temozolomide—brain cancer	0.000561	0.00221	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—HES5—brain cancer	0.000557	0.00425	CbGpPWpGaD
Octreotide—Sinusitis—Temozolomide—brain cancer	0.000556	0.00219	CcSEcCtD
Octreotide—Somnolence—Procarbazine—brain cancer	0.000556	0.00219	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—ABR—brain cancer	0.000555	0.00424	CbGpPWpGaD
Octreotide—Cramp muscle—Etoposide—brain cancer	0.000554	0.00218	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—DTX2—brain cancer	0.000551	0.00421	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—SMO—brain cancer	0.000551	0.00421	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—PTCH1—brain cancer	0.000551	0.00421	CbGpPWpGaD
Octreotide—Ill-defined disorder—Hydroxyurea—brain cancer	0.00055	0.00217	CcSEcCtD
Octreotide—Anaemia—Hydroxyurea—brain cancer	0.000548	0.00216	CcSEcCtD
Octreotide—Hypoaesthesia—Carmustine—brain cancer	0.000548	0.00216	CcSEcCtD
Octreotide—MPO—C-MYB transcription factor network—CDKN2A—brain cancer	0.000545	0.00416	CbGpPWpGaD
Octreotide—Decreased appetite—Procarbazine—brain cancer	0.000544	0.00214	CcSEcCtD
Octreotide—Oedema peripheral—Carmustine—brain cancer	0.000542	0.00214	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—ABR—brain cancer	0.000542	0.00414	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—STRADA—brain cancer	0.000541	0.00413	CbGpPWpGaD
Octreotide—Fatigue—Procarbazine—brain cancer	0.000539	0.00212	CcSEcCtD
Octreotide—Malaise—Hydroxyurea—brain cancer	0.000535	0.00211	CcSEcCtD
Octreotide—Pain—Procarbazine—brain cancer	0.000535	0.00211	CcSEcCtD
Octreotide—Constipation—Procarbazine—brain cancer	0.000535	0.00211	CcSEcCtD
Octreotide—SSTR4—GPCR downstream signaling—TRPC6—brain cancer	0.000532	0.00407	CbGpPWpGaD
Octreotide—Hepatitis—Temozolomide—brain cancer	0.000532	0.0021	CcSEcCtD
Octreotide—Visual impairment—Carmustine—brain cancer	0.000531	0.00209	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—OR14C36—brain cancer	0.000531	0.00405	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—OR4C12—brain cancer	0.000531	0.00405	CbGpPWpGaD
Octreotide—Hypoaesthesia—Temozolomide—brain cancer	0.000529	0.00208	CcSEcCtD
Octreotide—Pharyngitis—Temozolomide—brain cancer	0.000528	0.00208	CcSEcCtD
Octreotide—Oedema peripheral—Temozolomide—brain cancer	0.000524	0.00206	CcSEcCtD
Octreotide—Bronchospasm—Etoposide—brain cancer	0.000523	0.00206	CcSEcCtD
Octreotide—Sweating increased—Etoposide—brain cancer	0.000518	0.00204	CcSEcCtD
Octreotide—Feeling abnormal—Procarbazine—brain cancer	0.000515	0.00203	CcSEcCtD
Octreotide—Convulsion—Hydroxyurea—brain cancer	0.000514	0.00202	CcSEcCtD
Octreotide—Visual impairment—Temozolomide—brain cancer	0.000513	0.00202	CcSEcCtD
Octreotide—Gastrointestinal pain—Procarbazine—brain cancer	0.000511	0.00201	CcSEcCtD
Octreotide—Flushing—Carmustine—brain cancer	0.000511	0.00201	CcSEcCtD
Octreotide—SSTR1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000507	0.00387	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—RELA—brain cancer	0.000505	0.00386	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—SHH—brain cancer	0.000501	0.00383	CbGpPWpGaD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000501	0.00197	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—ABR—brain cancer	0.0005	0.00382	CbGpPWpGaD
Octreotide—Discomfort—Hydroxyurea—brain cancer	0.000499	0.00196	CcSEcCtD
Octreotide—Urticaria—Procarbazine—brain cancer	0.000497	0.00196	CcSEcCtD
Octreotide—Tinnitus—Temozolomide—brain cancer	0.000496	0.00195	CcSEcCtD
Octreotide—Abdominal pain—Procarbazine—brain cancer	0.000494	0.00195	CcSEcCtD
Octreotide—Body temperature increased—Procarbazine—brain cancer	0.000494	0.00195	CcSEcCtD
Octreotide—Flushing—Temozolomide—brain cancer	0.000494	0.00194	CcSEcCtD
Octreotide—Cardiac disorder—Temozolomide—brain cancer	0.000494	0.00194	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—ABR—brain cancer	0.000492	0.00376	CbGpPWpGaD
Octreotide—Arrhythmia—Carmustine—brain cancer	0.000492	0.00194	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—DTX2—brain cancer	0.000489	0.00374	CbGpPWpGaD
Octreotide—Alopecia—Carmustine—brain cancer	0.000487	0.00192	CcSEcCtD
Octreotide—Oedema—Hydroxyurea—brain cancer	0.000484	0.00191	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—TRPC6—brain cancer	0.000483	0.00369	CbGpPWpGaD
Octreotide—Mental disorder—Carmustine—brain cancer	0.000482	0.0019	CcSEcCtD
Octreotide—Infection—Hydroxyurea—brain cancer	0.000481	0.00189	CcSEcCtD
Octreotide—Immune system disorder—Temozolomide—brain cancer	0.000481	0.00189	CcSEcCtD
Octreotide—Erythema—Carmustine—brain cancer	0.000479	0.00189	CcSEcCtD
Octreotide—Malnutrition—Carmustine—brain cancer	0.000479	0.00189	CcSEcCtD
Octreotide—Pneumonia—Etoposide—brain cancer	0.000477	0.00188	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—PTCH1—brain cancer	0.000475	0.00363	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—SMO—brain cancer	0.000475	0.00363	CbGpPWpGaD
Octreotide—Nervous system disorder—Hydroxyurea—brain cancer	0.000475	0.00187	CcSEcCtD
Octreotide—Thrombocytopenia—Hydroxyurea—brain cancer	0.000474	0.00187	CcSEcCtD
Octreotide—Alopecia—Temozolomide—brain cancer	0.00047	0.00185	CcSEcCtD
Octreotide—Skin disorder—Hydroxyurea—brain cancer	0.00047	0.00185	CcSEcCtD
Octreotide—Mental disorder—Temozolomide—brain cancer	0.000466	0.00184	CcSEcCtD
Octreotide—Neuropathy peripheral—Etoposide—brain cancer	0.000465	0.00183	CcSEcCtD
Octreotide—Back pain—Carmustine—brain cancer	0.000464	0.00183	CcSEcCtD
Octreotide—Malnutrition—Temozolomide—brain cancer	0.000463	0.00182	CcSEcCtD
Octreotide—Erythema—Temozolomide—brain cancer	0.000463	0.00182	CcSEcCtD
Octreotide—Jaundice—Etoposide—brain cancer	0.000462	0.00182	CcSEcCtD
Octreotide—Anorexia—Hydroxyurea—brain cancer	0.000461	0.00182	CcSEcCtD
Octreotide—Hypersensitivity—Procarbazine—brain cancer	0.000461	0.00181	CcSEcCtD
Octreotide—MPO—C-MYB transcription factor network—CCND1—brain cancer	0.00046	0.00352	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—ABR—brain cancer	0.000454	0.00347	CbGpPWpGaD
Octreotide—Vision blurred—Carmustine—brain cancer	0.000452	0.00178	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—DTX2—brain cancer	0.000451	0.00345	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—ABR—brain cancer	0.000451	0.00345	CbGpPWpGaD
Octreotide—Tremor—Carmustine—brain cancer	0.000449	0.00177	CcSEcCtD
Octreotide—Asthenia—Procarbazine—brain cancer	0.000449	0.00177	CcSEcCtD
Octreotide—Hepatobiliary disease—Etoposide—brain cancer	0.000449	0.00177	CcSEcCtD
Octreotide—Back pain—Temozolomide—brain cancer	0.000448	0.00176	CcSEcCtD
Octreotide—SSTR1—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000446	0.00341	CbGpPWpGaD
Octreotide—Anaemia—Carmustine—brain cancer	0.000443	0.00174	CcSEcCtD
Octreotide—Pruritus—Procarbazine—brain cancer	0.000442	0.00174	CcSEcCtD
Octreotide—Agitation—Carmustine—brain cancer	0.00044	0.00173	CcSEcCtD
Octreotide—Vision blurred—Temozolomide—brain cancer	0.000437	0.00172	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—GLI2—brain cancer	0.000436	0.00333	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PTCH2—brain cancer	0.000436	0.00333	CbGpPWpGaD
Octreotide—Tremor—Temozolomide—brain cancer	0.000434	0.00171	CcSEcCtD
Octreotide—Dyspnoea—Hydroxyurea—brain cancer	0.000431	0.0017	CcSEcCtD
Octreotide—Somnolence—Hydroxyurea—brain cancer	0.00043	0.00169	CcSEcCtD
Octreotide—Ill-defined disorder—Temozolomide—brain cancer	0.00043	0.00169	CcSEcCtD
Octreotide—Anaemia—Temozolomide—brain cancer	0.000428	0.00169	CcSEcCtD
Octreotide—Diarrhoea—Procarbazine—brain cancer	0.000428	0.00168	CcSEcCtD
Octreotide—Dyspepsia—Hydroxyurea—brain cancer	0.000426	0.00168	CcSEcCtD
Octreotide—Agitation—Temozolomide—brain cancer	0.000426	0.00168	CcSEcCtD
Octreotide—Hypoaesthesia—Etoposide—brain cancer	0.000424	0.00167	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—HES5—brain cancer	0.000422	0.00322	CbGpPWpGaD
Octreotide—Decreased appetite—Hydroxyurea—brain cancer	0.000421	0.00166	CcSEcCtD
Octreotide—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000418	0.00164	CcSEcCtD
Octreotide—Malaise—Temozolomide—brain cancer	0.000418	0.00164	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—PTCH2—brain cancer	0.000418	0.00319	CbGpPWpGaD
Octreotide—Fatigue—Hydroxyurea—brain cancer	0.000417	0.00164	CcSEcCtD
Octreotide—Vertigo—Temozolomide—brain cancer	0.000416	0.00164	CcSEcCtD
Octreotide—Convulsion—Carmustine—brain cancer	0.000415	0.00164	CcSEcCtD
Octreotide—SSTR2—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000415	0.00317	CbGpPWpGaD
Octreotide—Hypertension—Carmustine—brain cancer	0.000414	0.00163	CcSEcCtD
Octreotide—Constipation—Hydroxyurea—brain cancer	0.000414	0.00163	CcSEcCtD
Octreotide—Pain—Hydroxyurea—brain cancer	0.000414	0.00163	CcSEcCtD
Octreotide—Dizziness—Procarbazine—brain cancer	0.000413	0.00163	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—STRADA—brain cancer	0.00041	0.00313	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—GLI1—brain cancer	0.00041	0.00313	CbGpPWpGaD
Octreotide—Palpitations—Temozolomide—brain cancer	0.000409	0.00161	CcSEcCtD
Octreotide—Chest pain—Carmustine—brain cancer	0.000408	0.00161	CcSEcCtD
Octreotide—Myalgia—Carmustine—brain cancer	0.000408	0.00161	CcSEcCtD
Octreotide—Anxiety—Carmustine—brain cancer	0.000407	0.0016	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—HES5—brain cancer	0.000405	0.00309	CbGpPWpGaD
Octreotide—Cough—Temozolomide—brain cancer	0.000404	0.00159	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—TRPC6—brain cancer	0.000403	0.00308	CbGpPWpGaD
Octreotide—Convulsion—Temozolomide—brain cancer	0.000401	0.00158	CcSEcCtD
Octreotide—Hypertension—Temozolomide—brain cancer	0.0004	0.00157	CcSEcCtD
Octreotide—SSTR4—GPCR downstream signaling—VAV1—brain cancer	0.000399	0.00305	CbGpPWpGaD
Octreotide—Feeling abnormal—Hydroxyurea—brain cancer	0.000399	0.00157	CcSEcCtD
Octreotide—Vomiting—Procarbazine—brain cancer	0.000398	0.00157	CcSEcCtD
Octreotide—Flushing—Etoposide—brain cancer	0.000395	0.00156	CcSEcCtD
Octreotide—Cardiac disorder—Etoposide—brain cancer	0.000395	0.00156	CcSEcCtD
Octreotide—Arthralgia—Temozolomide—brain cancer	0.000394	0.00155	CcSEcCtD
Octreotide—Myalgia—Temozolomide—brain cancer	0.000394	0.00155	CcSEcCtD
Octreotide—Rash—Procarbazine—brain cancer	0.000394	0.00155	CcSEcCtD
Octreotide—Dermatitis—Procarbazine—brain cancer	0.000394	0.00155	CcSEcCtD
Octreotide—Anxiety—Temozolomide—brain cancer	0.000393	0.00155	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—STRADA—brain cancer	0.000393	0.003	CbGpPWpGaD
Octreotide—Headache—Procarbazine—brain cancer	0.000392	0.00154	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000392	0.00154	CcSEcCtD
Octreotide—Oedema—Carmustine—brain cancer	0.000391	0.00154	CcSEcCtD
Octreotide—Discomfort—Temozolomide—brain cancer	0.00039	0.00153	CcSEcCtD
Octreotide—Infection—Carmustine—brain cancer	0.000389	0.00153	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—SUFU—brain cancer	0.000388	0.00297	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—TRPC6—brain cancer	0.000387	0.00296	CbGpPWpGaD
Octreotide—Dry mouth—Temozolomide—brain cancer	0.000386	0.00152	CcSEcCtD
Octreotide—Immune system disorder—Etoposide—brain cancer	0.000385	0.00151	CcSEcCtD
Octreotide—Thrombocytopenia—Carmustine—brain cancer	0.000383	0.00151	CcSEcCtD
Octreotide—Body temperature increased—Hydroxyurea—brain cancer	0.000383	0.00151	CcSEcCtD
Octreotide—Tachycardia—Carmustine—brain cancer	0.000382	0.0015	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—SHH—brain cancer	0.00038	0.0029	CbGpPWpGaD
Octreotide—Anaphylactic shock—Temozolomide—brain cancer	0.000378	0.00149	CcSEcCtD
Octreotide—Oedema—Temozolomide—brain cancer	0.000378	0.00149	CcSEcCtD
Octreotide—Alopecia—Etoposide—brain cancer	0.000376	0.00148	CcSEcCtD
Octreotide—Infection—Temozolomide—brain cancer	0.000376	0.00148	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—GFAP—brain cancer	0.000375	0.00286	CbGpPWpGaD
Octreotide—Anorexia—Carmustine—brain cancer	0.000373	0.00147	CcSEcCtD
Octreotide—Nausea—Procarbazine—brain cancer	0.000371	0.00146	CcSEcCtD
Octreotide—Nervous system disorder—Temozolomide—brain cancer	0.000371	0.00146	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—PTCH2—brain cancer	0.00037	0.00283	CbGpPWpGaD
Octreotide—Thrombocytopenia—Temozolomide—brain cancer	0.00037	0.00146	CcSEcCtD
Octreotide—MPO—C-MYB transcription factor network—MYC—brain cancer	0.000369	0.00282	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—TP53—brain cancer	0.000368	0.00281	CbGpPWpGaD
Octreotide—Skin disorder—Temozolomide—brain cancer	0.000367	0.00145	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—TRPC6—brain cancer	0.000366	0.0028	CbGpPWpGaD
Octreotide—Hyperhidrosis—Temozolomide—brain cancer	0.000365	0.00144	CcSEcCtD
Octreotide—SSTR2—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000365	0.00279	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—SHH—brain cancer	0.000364	0.00278	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—VAV1—brain cancer	0.000362	0.00277	CbGpPWpGaD
Octreotide—Anorexia—Temozolomide—brain cancer	0.00036	0.00142	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—SMO—brain cancer	0.00036	0.00275	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PTCH1—brain cancer	0.00036	0.00275	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HES5—brain cancer	0.000359	0.00274	CbGpPWpGaD
Octreotide—Back pain—Etoposide—brain cancer	0.000359	0.00141	CcSEcCtD
Octreotide—Hypersensitivity—Hydroxyurea—brain cancer	0.000357	0.0014	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Carmustine—brain cancer	0.000356	0.0014	CcSEcCtD
Octreotide—Muscle spasms—Etoposide—brain cancer	0.000356	0.0014	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—HEY1—brain cancer	0.000355	0.00271	CbGpPWpGaD
Octreotide—Insomnia—Carmustine—brain cancer	0.000354	0.00139	CcSEcCtD
Octreotide—Paraesthesia—Carmustine—brain cancer	0.000351	0.00138	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—TRPC6—brain cancer	0.000351	0.00268	CbGpPWpGaD
Octreotide—Dyspnoea—Carmustine—brain cancer	0.000349	0.00137	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—STRADA—brain cancer	0.000348	0.00266	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—DLL1—brain cancer	0.000348	0.00266	CbGpPWpGaD
Octreotide—Somnolence—Carmustine—brain cancer	0.000348	0.00137	CcSEcCtD
Octreotide—Asthenia—Hydroxyurea—brain cancer	0.000347	0.00137	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—SMO—brain cancer	0.000345	0.00264	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PTCH1—brain cancer	0.000345	0.00264	CbGpPWpGaD
Octreotide—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000344	0.00136	CcSEcCtD
Octreotide—Ill-defined disorder—Etoposide—brain cancer	0.000344	0.00135	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—TRPC6—brain cancer	0.000343	0.00262	CbGpPWpGaD
Octreotide—Anaemia—Etoposide—brain cancer	0.000343	0.00135	CcSEcCtD
Octreotide—Insomnia—Temozolomide—brain cancer	0.000342	0.00135	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—PTCH2—brain cancer	0.000342	0.00261	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—ABR—brain cancer	0.000342	0.00261	CbGpPWpGaD
Octreotide—Decreased appetite—Carmustine—brain cancer	0.00034	0.00134	CcSEcCtD
Octreotide—Paraesthesia—Temozolomide—brain cancer	0.000339	0.00134	CcSEcCtD
Octreotide—Gastrointestinal disorder—Carmustine—brain cancer	0.000338	0.00133	CcSEcCtD
Octreotide—Dyspnoea—Temozolomide—brain cancer	0.000337	0.00133	CcSEcCtD
Octreotide—Somnolence—Temozolomide—brain cancer	0.000336	0.00132	CcSEcCtD
Octreotide—Constipation—Carmustine—brain cancer	0.000335	0.00132	CcSEcCtD
Octreotide—Pain—Carmustine—brain cancer	0.000335	0.00132	CcSEcCtD
Octreotide—Malaise—Etoposide—brain cancer	0.000334	0.00132	CcSEcCtD
Octreotide—Vertigo—Etoposide—brain cancer	0.000333	0.00131	CcSEcCtD
Octreotide—Dyspepsia—Temozolomide—brain cancer	0.000333	0.00131	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—HES5—brain cancer	0.000331	0.00253	CbGpPWpGaD
Octreotide—Diarrhoea—Hydroxyurea—brain cancer	0.000331	0.0013	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—GLI2—brain cancer	0.00033	0.00252	CbGpPWpGaD
Octreotide—Decreased appetite—Temozolomide—brain cancer	0.000329	0.00129	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—ABR—brain cancer	0.000328	0.0025	CbGpPWpGaD
Octreotide—Gastrointestinal disorder—Temozolomide—brain cancer	0.000326	0.00129	CcSEcCtD
Octreotide—Fatigue—Temozolomide—brain cancer	0.000326	0.00128	CcSEcCtD
Octreotide—Loss of consciousness—Etoposide—brain cancer	0.000326	0.00128	CcSEcCtD
Octreotide—Cough—Etoposide—brain cancer	0.000323	0.00127	CcSEcCtD
Octreotide—Constipation—Temozolomide—brain cancer	0.000323	0.00127	CcSEcCtD
Octreotide—Pain—Temozolomide—brain cancer	0.000323	0.00127	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—SHH—brain cancer	0.000323	0.00247	CbGpPWpGaD
Octreotide—Feeling abnormal—Carmustine—brain cancer	0.000322	0.00127	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—STRADA—brain cancer	0.000321	0.00246	CbGpPWpGaD
Octreotide—Convulsion—Etoposide—brain cancer	0.000321	0.00126	CcSEcCtD
Octreotide—Hypertension—Etoposide—brain cancer	0.00032	0.00126	CcSEcCtD
Octreotide—Dizziness—Hydroxyurea—brain cancer	0.00032	0.00126	CcSEcCtD
Octreotide—Gastrointestinal pain—Carmustine—brain cancer	0.00032	0.00126	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—TRPC6—brain cancer	0.000317	0.00242	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—GLI2—brain cancer	0.000317	0.00242	CbGpPWpGaD
Octreotide—Chest pain—Etoposide—brain cancer	0.000316	0.00124	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000313	0.00123	CcSEcCtD
Octreotide—Discomfort—Etoposide—brain cancer	0.000312	0.00123	CcSEcCtD
Octreotide—Feeling abnormal—Temozolomide—brain cancer	0.000312	0.00123	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—TRPC6—brain cancer	0.000312	0.00238	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—GLI1—brain cancer	0.00031	0.00237	CbGpPWpGaD
Octreotide—Body temperature increased—Carmustine—brain cancer	0.000309	0.00122	CcSEcCtD
Octreotide—Abdominal pain—Carmustine—brain cancer	0.000309	0.00122	CcSEcCtD
Octreotide—Gastrointestinal pain—Temozolomide—brain cancer	0.000309	0.00122	CcSEcCtD
Octreotide—Vomiting—Hydroxyurea—brain cancer	0.000308	0.00121	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—PTCH1—brain cancer	0.000306	0.00234	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—SMO—brain cancer	0.000306	0.00234	CbGpPWpGaD
Octreotide—Rash—Hydroxyurea—brain cancer	0.000305	0.0012	CcSEcCtD
Octreotide—Dermatitis—Hydroxyurea—brain cancer	0.000305	0.0012	CcSEcCtD
Octreotide—Headache—Hydroxyurea—brain cancer	0.000303	0.00119	CcSEcCtD
Octreotide—Anaphylactic shock—Etoposide—brain cancer	0.000303	0.00119	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—VAV1—brain cancer	0.000302	0.00231	CbGpPWpGaD
Octreotide—Infection—Etoposide—brain cancer	0.000301	0.00118	CcSEcCtD
Octreotide—Urticaria—Temozolomide—brain cancer	0.0003	0.00118	CcSEcCtD
Octreotide—Abdominal pain—Temozolomide—brain cancer	0.000299	0.00118	CcSEcCtD
Octreotide—Body temperature increased—Temozolomide—brain cancer	0.000299	0.00118	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—SHH—brain cancer	0.000298	0.00228	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—GLI1—brain cancer	0.000298	0.00227	CbGpPWpGaD
Octreotide—Thrombocytopenia—Etoposide—brain cancer	0.000296	0.00117	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—SHH—brain cancer	0.000296	0.00226	CbGpPWpGaD
Octreotide—Tachycardia—Etoposide—brain cancer	0.000295	0.00116	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—SUFU—brain cancer	0.000294	0.00225	CbGpPWpGaD
Octreotide—Skin disorder—Etoposide—brain cancer	0.000294	0.00116	CcSEcCtD
Octreotide—Hyperhidrosis—Etoposide—brain cancer	0.000292	0.00115	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—ABR—brain cancer	0.000291	0.00222	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—VAV1—brain cancer	0.00029	0.00221	CbGpPWpGaD
Octreotide—Anorexia—Etoposide—brain cancer	0.000288	0.00114	CcSEcCtD
Octreotide—Hypersensitivity—Carmustine—brain cancer	0.000288	0.00113	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—TRPC6—brain cancer	0.000287	0.0022	CbGpPWpGaD
Octreotide—Nausea—Hydroxyurea—brain cancer	0.000287	0.00113	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—TRPC6—brain cancer	0.000286	0.00218	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—GFAP—brain cancer	0.000284	0.00217	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PTCH1—brain cancer	0.000283	0.00216	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—SMO—brain cancer	0.000283	0.00216	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SUFU—brain cancer	0.000282	0.00216	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—GLI2—brain cancer	0.000281	0.00215	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PTCH1—brain cancer	0.000281	0.00215	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—SMO—brain cancer	0.000281	0.00215	CbGpPWpGaD
Octreotide—Asthenia—Carmustine—brain cancer	0.000281	0.00111	CcSEcCtD
Octreotide—Hypersensitivity—Temozolomide—brain cancer	0.000279	0.0011	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—VAV1—brain cancer	0.000275	0.0021	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—GFAP—brain cancer	0.000272	0.00208	CbGpPWpGaD
Octreotide—Paraesthesia—Etoposide—brain cancer	0.000272	0.00107	CcSEcCtD
Octreotide—Asthenia—Temozolomide—brain cancer	0.000271	0.00107	CcSEcCtD
Octreotide—Dyspnoea—Etoposide—brain cancer	0.00027	0.00106	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—HEY1—brain cancer	0.000269	0.00206	CbGpPWpGaD
Octreotide—Somnolence—Etoposide—brain cancer	0.000269	0.00106	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—ABR—brain cancer	0.000268	0.00205	CbGpPWpGaD
Octreotide—Diarrhoea—Carmustine—brain cancer	0.000268	0.00105	CcSEcCtD
Octreotide—Pruritus—Temozolomide—brain cancer	0.000267	0.00105	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—DLL1—brain cancer	0.000264	0.00202	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—GLI1—brain cancer	0.000264	0.00202	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—VAV1—brain cancer	0.000263	0.00201	CbGpPWpGaD
Octreotide—Decreased appetite—Etoposide—brain cancer	0.000263	0.00104	CcSEcCtD
Octreotide—Gastrointestinal disorder—Etoposide—brain cancer	0.000261	0.00103	CcSEcCtD
Octreotide—Fatigue—Etoposide—brain cancer	0.000261	0.00103	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—GLI2—brain cancer	0.000259	0.00198	CbGpPWpGaD
Octreotide—Dizziness—Carmustine—brain cancer	0.000259	0.00102	CcSEcCtD
Octreotide—Pain—Etoposide—brain cancer	0.000259	0.00102	CcSEcCtD
Octreotide—Constipation—Etoposide—brain cancer	0.000259	0.00102	CcSEcCtD
Octreotide—Diarrhoea—Temozolomide—brain cancer	0.000259	0.00102	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—HEY1—brain cancer	0.000258	0.00197	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—VAV1—brain cancer	0.000257	0.00196	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—PIK3CG—brain cancer	0.000253	0.00194	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—DLL1—brain cancer	0.000253	0.00193	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SUFU—brain cancer	0.00025	0.00191	CbGpPWpGaD
Octreotide—Dizziness—Temozolomide—brain cancer	0.00025	0.000984	CcSEcCtD
Octreotide—Feeling abnormal—Etoposide—brain cancer	0.000249	0.000981	CcSEcCtD
Octreotide—Vomiting—Carmustine—brain cancer	0.000249	0.000979	CcSEcCtD
Octreotide—Gastrointestinal pain—Etoposide—brain cancer	0.000247	0.000974	CcSEcCtD
Octreotide—Rash—Carmustine—brain cancer	0.000247	0.000971	CcSEcCtD
Octreotide—Dermatitis—Carmustine—brain cancer	0.000246	0.00097	CcSEcCtD
Octreotide—Headache—Carmustine—brain cancer	0.000245	0.000965	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—GLI1—brain cancer	0.000244	0.00186	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—GFAP—brain cancer	0.000241	0.00184	CbGpPWpGaD
Octreotide—Vomiting—Temozolomide—brain cancer	0.00024	0.000946	CcSEcCtD
Octreotide—Urticaria—Etoposide—brain cancer	0.00024	0.000946	CcSEcCtD
Octreotide—Abdominal pain—Etoposide—brain cancer	0.000239	0.000942	CcSEcCtD
Octreotide—Body temperature increased—Etoposide—brain cancer	0.000239	0.000942	CcSEcCtD
Octreotide—Rash—Temozolomide—brain cancer	0.000238	0.000938	CcSEcCtD
Octreotide—Dermatitis—Temozolomide—brain cancer	0.000238	0.000938	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—VAV1—brain cancer	0.000237	0.00181	CbGpPWpGaD
Octreotide—Headache—Temozolomide—brain cancer	0.000237	0.000932	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—VAV1—brain cancer	0.000233	0.00178	CbGpPWpGaD
Octreotide—Nausea—Carmustine—brain cancer	0.000232	0.000915	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—SUFU—brain cancer	0.000231	0.00176	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—PIK3CG—brain cancer	0.00023	0.00176	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HEY1—brain cancer	0.000229	0.00175	CbGpPWpGaD
Octreotide—Nausea—Temozolomide—brain cancer	0.000225	0.000884	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—DLL1—brain cancer	0.000224	0.00172	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—NOTCH2—brain cancer	0.000224	0.00172	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SHH—brain cancer	0.000224	0.00172	CbGpPWpGaD
Octreotide—Hypersensitivity—Etoposide—brain cancer	0.000223	0.000878	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—GFAP—brain cancer	0.000223	0.0017	CbGpPWpGaD
Octreotide—Asthenia—Etoposide—brain cancer	0.000217	0.000855	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—TRPC6—brain cancer	0.000216	0.00165	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—VAV1—brain cancer	0.000215	0.00165	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SHH—brain cancer	0.000215	0.00164	CbGpPWpGaD
Octreotide—Pruritus—Etoposide—brain cancer	0.000214	0.000843	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—VAV1—brain cancer	0.000214	0.00163	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PTCH1—brain cancer	0.000213	0.00163	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SMO—brain cancer	0.000213	0.00163	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HEY1—brain cancer	0.000211	0.00161	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TRPC6—brain cancer	0.000207	0.00159	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—DLL1—brain cancer	0.000207	0.00158	CbGpPWpGaD
Octreotide—Diarrhoea—Etoposide—brain cancer	0.000207	0.000815	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—SMO—brain cancer	0.000204	0.00156	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PTCH1—brain cancer	0.000204	0.00156	CbGpPWpGaD
Octreotide—Dizziness—Etoposide—brain cancer	0.0002	0.000788	CcSEcCtD
Octreotide—Vomiting—Etoposide—brain cancer	0.000192	0.000757	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—PIK3CG—brain cancer	0.000192	0.00147	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SHH—brain cancer	0.000191	0.00146	CbGpPWpGaD
Octreotide—Rash—Etoposide—brain cancer	0.000191	0.000751	CcSEcCtD
Octreotide—Dermatitis—Etoposide—brain cancer	0.000191	0.00075	CcSEcCtD
Octreotide—Headache—Etoposide—brain cancer	0.00019	0.000746	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—TRPC6—brain cancer	0.000184	0.00141	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—HES1—brain cancer	0.000184	0.00141	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—PIK3CG—brain cancer	0.000184	0.00141	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PTCH1—brain cancer	0.000181	0.00138	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SMO—brain cancer	0.000181	0.00138	CbGpPWpGaD
Octreotide—Nausea—Etoposide—brain cancer	0.00018	0.000707	CcSEcCtD
Octreotide—SSTR4—GPCR downstream signaling—IL2—brain cancer	0.000178	0.00136	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SHH—brain cancer	0.000176	0.00135	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PDGFRA—brain cancer	0.000175	0.00134	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PIK3CG—brain cancer	0.000174	0.00133	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—SPP1—brain cancer	0.00017	0.0013	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NOTCH2—brain cancer	0.00017	0.0013	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TRPC6—brain cancer	0.00017	0.0013	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PIK3CG—brain cancer	0.000167	0.00128	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PTCH1—brain cancer	0.000167	0.00128	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SMO—brain cancer	0.000167	0.00128	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—PIK3CG—brain cancer	0.000163	0.00125	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NOTCH2—brain cancer	0.000163	0.00125	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—VAV1—brain cancer	0.000162	0.00124	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—IL2—brain cancer	0.000162	0.00124	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—VAV1—brain cancer	0.000155	0.00119	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IRS2—brain cancer	0.000154	0.00118	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PIK3CG—brain cancer	0.000151	0.00115	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PIK3CG—brain cancer	0.000148	0.00113	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NOTCH2—brain cancer	0.000145	0.00111	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HES1—brain cancer	0.000139	0.00107	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—VAV1—brain cancer	0.000138	0.00105	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PIK3CG—brain cancer	0.000137	0.00105	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PIK3CG—brain cancer	0.000136	0.00104	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—APC—brain cancer	0.000136	0.00104	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—IL2—brain cancer	0.000135	0.00103	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HES1—brain cancer	0.000134	0.00102	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NOTCH2—brain cancer	0.000133	0.00102	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PDGFRA—brain cancer	0.000133	0.00101	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—IL2—brain cancer	0.000129	0.000989	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SPP1—brain cancer	0.000129	0.000985	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PDGFRA—brain cancer	0.000127	0.000973	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—VAV1—brain cancer	0.000127	0.000972	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—EGFR—brain cancer	0.000124	0.000946	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SPP1—brain cancer	0.000124	0.000944	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—IL2—brain cancer	0.000123	0.000937	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HES1—brain cancer	0.000119	0.000906	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—IL2—brain cancer	0.000118	0.000899	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IRS2—brain cancer	0.000117	0.000891	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—IL2—brain cancer	0.000115	0.000878	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PDGFRA—brain cancer	0.000113	0.000863	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IRS2—brain cancer	0.000112	0.000854	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SPP1—brain cancer	0.00011	0.000838	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HES1—brain cancer	0.000109	0.000836	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—RELA—brain cancer	0.000106	0.000811	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—IL2—brain cancer	0.000106	0.00081	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—ERBB2—brain cancer	0.000105	0.000806	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL2—brain cancer	0.000104	0.000797	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PDGFRA—brain cancer	0.000104	0.000796	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CG—brain cancer	0.000103	0.000787	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—APC—brain cancer	0.000103	0.000787	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SPP1—brain cancer	0.000101	0.000773	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IRS2—brain cancer	9.91e-05	0.000757	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—APC—brain cancer	9.87e-05	0.000754	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CG—brain cancer	9.87e-05	0.000754	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL2—brain cancer	9.62e-05	0.000735	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL2—brain cancer	9.56e-05	0.000731	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—EGFR—brain cancer	9.38e-05	0.000717	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CCND1—brain cancer	9.32e-05	0.000712	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CTNNB1—brain cancer	9.23e-05	0.000705	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IRS2—brain cancer	9.15e-05	0.000699	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—EGFR—brain cancer	8.99e-05	0.000687	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—APC—brain cancer	8.75e-05	0.000669	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CG—brain cancer	8.75e-05	0.000669	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—VEGFA—brain cancer	8.13e-05	0.000621	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—APC—brain cancer	8.08e-05	0.000617	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CG—brain cancer	8.08e-05	0.000617	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—STAT3—brain cancer	8.05e-05	0.000615	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—RELA—brain cancer	8.05e-05	0.000615	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—ERBB2—brain cancer	7.99e-05	0.000611	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—EGFR—brain cancer	7.98e-05	0.000609	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—RELA—brain cancer	7.71e-05	0.000589	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—ERBB2—brain cancer	7.66e-05	0.000586	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MYC—brain cancer	7.48e-05	0.000571	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—EGFR—brain cancer	7.36e-05	0.000562	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—EGFR—brain cancer	7.31e-05	0.000559	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL2—brain cancer	7.25e-05	0.000554	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CCND1—brain cancer	7.06e-05	0.00054	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CTNNB1—brain cancer	6.99e-05	0.000534	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL2—brain cancer	6.95e-05	0.000531	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RELA—brain cancer	6.84e-05	0.000523	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ERBB2—brain cancer	6.8e-05	0.000519	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CCND1—brain cancer	6.77e-05	0.000517	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CTNNB1—brain cancer	6.71e-05	0.000512	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—RELA—brain cancer	6.31e-05	0.000482	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ERBB2—brain cancer	6.27e-05	0.000479	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL2—brain cancer	6.16e-05	0.000471	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—VEGFA—brain cancer	6.16e-05	0.000471	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TP53—brain cancer	6.14e-05	0.000469	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—STAT3—brain cancer	6.1e-05	0.000466	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCND1—brain cancer	6.01e-05	0.000459	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CTNNB1—brain cancer	5.95e-05	0.000454	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—VEGFA—brain cancer	5.9e-05	0.000451	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—STAT3—brain cancer	5.85e-05	0.000447	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL2—brain cancer	5.69e-05	0.000434	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MYC—brain cancer	5.67e-05	0.000433	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCND1—brain cancer	5.54e-05	0.000424	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—EGFR—brain cancer	5.54e-05	0.000423	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CTNNB1—brain cancer	5.49e-05	0.000419	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MYC—brain cancer	5.43e-05	0.000415	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—EGFR—brain cancer	5.31e-05	0.000406	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—VEGFA—brain cancer	5.24e-05	0.0004	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—STAT3—brain cancer	5.18e-05	0.000396	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—VEGFA—brain cancer	4.83e-05	0.000369	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MYC—brain cancer	4.82e-05	0.000368	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—STAT3—brain cancer	4.78e-05	0.000366	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—EGFR—brain cancer	4.71e-05	0.00036	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TP53—brain cancer	4.65e-05	0.000356	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TP53—brain cancer	4.46e-05	0.000341	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MYC—brain cancer	4.45e-05	0.00034	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—EGFR—brain cancer	4.35e-05	0.000332	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TP53—brain cancer	3.96e-05	0.000302	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TP53—brain cancer	3.65e-05	0.000279	CbGpPWpGaD
